LJUBLJANA, July 6 (Reuters) - Group net profit for
Slovenia's generic drug producer Krka KRKG.LJ rose by 31
percent to 91.7 million euros ($104.4 million) in the first half
of the year, according to an initial estimate of the figures,
Krka said in a statement on Thursday.
It said sales rose by 8.5 percent to 655 million euros,
adding final H1 figures would be released on July 27.
($1 = 0.8781 euros)
(Reporting By Marja Novak; Editing by Keith Weir)
((Marja.Novak@thomsonreuters.com; +386-1-5058805, Reuters
Messaging: marja.novak.thomsonreuters.com@reuters.net))
Keywords: KRKA RESULTS/